Mesna
From Anvita Health Wiki
Contents |
Introduction
- main ingredient is 2-mercaptoethanesulfonate.
- Tradename: Mesnex
Indications
- uroprotective agent used to decrease the incidence of hemorrhagic cystitis in patients receiving cyclophosphamide or ifosfamide
Contraindications
- * incompatible with cisplatin
Dosage
- mesna is used in combination with cyclophosphamide & ifosfamide
- 60% of ifosfamide or cyclophosphamide dose
- 20% before 20% 4 hours after 20% 8 hours after ifosfamide or cyclophosphamide dose, or
- equal to ifosfamide or cyclophosphamide dose, delivered continuously
- dose just prior to chemotherapy should be IV
- 4 & 8 hours doses may be oral or IV
- oral doses should be mixed in tomato juice, orange juice, or a carbonated drink
- Injection: 100 mg/mL (2 mL, 4 mL, 10 mL).
Storage
- Diluted solutions are stable for 24 hours at room temerature, but recommendations are for refrigeration & use within 6 hours.
Pharmacokinetics
- elimination via urine
- 1/2life = 1 hour
Adverse-effects
- not common (1-10%)
- hypotension, malaise, headache, diarrhea, nausea/vomiting (mild), taste disturbance, limb pain, soft stools
- uncommon (< 1%)
Drug-interactions
- mesna inhibits anti- neoplastic effects of cisplatin & carboplatin
Test-interactions
- false positive urine ketone test
Mechanism-of-action
- sulfhydryl compound that binds to irritating metabolites of ifosfamide & cyclophosphamide producing a non-toxic thiol ether
- slows the rate of acrolein formation
More General Terms
Additional Terms
- cyclophosphamide (Cytoxan, Neosar, Procytox {Canadian}) [CPM, CTX, CYT, NSC 26271]
- ifosfamide (Ifex, Friedman acid)
Internet Database
PubChem: 29769
PubChem: 598
PubChem: 4077
References
- Drug Information & Medication Formulary, Veterans Affairs, Central California Health Care System, 1st ed., Ravnan et al eds, 1998
- Kaiser Permanente Northern California Regional Drug Formulary, 1998
